

Cover Story
Free
By Matthew Bin Han Ong
Roche has teamed up with the precision medicine company Syapse to develop software for measuring health outcomes and economic impact of precision medicine.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health
- Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI